NOT A HOLE. AN EMERGING CATEGORY.
Micro Invasive Glaucoma Surgery (MIGS) is emerging to transform glaucoma therapy by offering new and compelling treatment options for the glaucoma patient. MIGS is also attracting attention both within and beyond ophthalmology. The Wall Street Journal (WSJ) recently selected and ranked Glaukos Corporation, the corporate leader of MIGS, number 7 out of a pool of 5,900 venture-capital-backed-companies.1 Glaukos as the nation's top healthcare start-up company. MIGS is beginning to change perspectives and the care of the glaucoma patient.
Moreover, the WSJ selected
To learn more contact Glaukos at 800.452.8567 or visit www.glaukos.com. REFERENCE: 1. Basich Z, Maltby E. Less Flash Draws More Cash: Ranking of Top 50 Start-Ups Reveals Focus on Business Technology as Health Care, Energy Fade. The Wall Street Journal. September 27, 2012:B1.
